NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Medical Letter on the CDC & FDA


Susan Hasty, Publisher
Table of Contents . . . June 14th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Medical Letter on the CDC & FDA | Other Publications

American Heart Association - More patients needed in clinical trials to find treatment for heart condition

BMJ-British Medical Journal - People with parents who fight are more likely to have mental health problems in later life

University of Texas M. D. Anderson Cancer Center - M. D. Anderson study finds dramatic increase in metastatic colon cancer survival

Arthritis - Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients

Bone Research - Researchers at Cleveland Clinic target bone research

Discectomy - Study findings on discectomy are outlined in reports from D. Murrey and colleagues

Hypertension - New hypertension study findings recently were reported by G.J. Peitz and co-researchers

Pharmaceuticals - New pharmaceuticals study findings have been published by scientists at University of Frankfurt

Pharmacokinetics - Report summarizes pharmacokinetics study findings from Cairo University

PolyMedix, Inc. - PolyMedix Receives Regulatory Clearance to Initiate Second Phase I Clinical Study of Novel Systemic Antibiotic Compound

Retinitis Pigmentosa - Results From Neurotech's NT-501 Phase 2 Retinitis Pigmentosa Studies Demonstrate Consistent Biological Effect on Photoreceptors

Vomiting - New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal

Anthrax - Reports from Harvard University, Medical Department add new data to research in anthrax

Anthrax - Researchers from Mahidol University report on findings in anthrax

Anthrax - Studies from University of Texas yield new information about anthrax

Dengue Fever - Researchers from Nanyang Technological University report details of new studies and findings in the area of dengue fever

Escherichia Coli - Study data from Queen's University provide new insights into Escherichia coli

Hantavirus - Research from K. Suzuki and co-researchers in the area of hantavirus described

Hantavirus - Research reports from P. Heyman and co-authors provide new insights into hantavirus

Legionnaire Disease - Findings from E. Wedege and co-authors broaden understanding of legionnaire disease

Life Sciences - New life sciences study findings recently were reported by researchers at Cornell University

Life Sciences - New life sciences study results reported from S.A. Girard et al

Life Sciences - Research from Washington State University provides new data on life sciences

Mass Spectrometry - New mass spectrometry study findings have been reported from R.R. Steiner et al

Plague - Data on plague discussed by J.L. Zhang and colleagues

Plague - Scientists at National Cancer Institute detail research in plague

Spinal Cord Injury - Recent studies by E. Gurcay and co-authors add new data to spinal cord injury findings

Thrombosis - Studies from Okayama University, Medical Department describe new findings in thrombosis

Vaccines - Studies from University of Illinois, Medical Department yield new information about vaccines

West Nile Virus - New west nile virus study findings reported from Army

West Nile Virus - Research on west nile virus detailed by H.E. Prince and co-authors

Carcinogenesis - Research reports from National Institute of Health Science, Division of Pathology provide new insights into carcinogenesis

Life Sciences - Reports summarize life sciences research from University of Copenhagen, Institute of Public Health

Academy of Managed Care Pharmacy AMCP - AMCP Sets Record Straight on Generic Drug Safety

Acusphere, Inc. - Acusphere, Inc. Announces Prepayment of Equipment Loans

Affymetrix Inc. - Affymetrix to Webcast Investor Day 2009

Allergan, Inc. - Allergan Receives Complete Response Letter for BOTOX® Botulinum Toxin Type a for Treatment of Upper Limb Spasticity in Adults

Allos Therapeutics, Inc. - Allos Therapeutics Announces FDA Accepts Pralatrexate NDA for Filing and Grants the Application Priority Review Status

AMRI - Phase I Testing to Commence on Second Compound Developed from AMRI, Bristol-Myers Squibb Collaboration

Anesthesiology - FDA Advisory Panel Recommends Approval of the SEDASYS(R) System

Anthrax Vaccines - PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA

Arteriocyte - Arteriocyte Medical Systems Announces Strategic Investment in Control Medical Technology

Bacterial Conjunctivitis - Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye')

Biotechnology Business - Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop

Bristol-Myers Squibb Company - FDA Grants Full Approval for SPRYCEL® dasatinib for the Treatment of Adults with Chronic Myeloid Leukemia Who Are Resistant or Intolerant to Prior Therapies Including Gleevec®*

Campaign for Tobacco-Free Kids - New Maine Poll: Voters Strongly Support FDA Regulation of Tobacco Products

Campaign for Tobacco-Free Kids - New Mississippi Poll: Voters Strongly Support FDA Regulation of Tobacco Products

Campaign for Tobacco-Free Kids - New Virginia Poll: 71 Percent of Voters Strongly Support FDA Regulation of Tobacco Products

Cancer - Agendia Supports Genentech's Citizen's Petition Urging FDA to Hold In-Vitro Diagnostic Tests to One Set of Scientific and Regulatory Standards

Centocor Ortho Biotech Inc. - FDA Extends Review Timeline for STELARA(TM) (ustekinumab) Biologic License Application by Three Months

Cerus Corporation - Cerus and Grifols Extend INTERCEPT Blood System Distribution to Italy

Clinipace - Clinipace to Manage Two Phase II Clinical Trials for Inspire Pharmaceuticals

Clostridium - ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products

Cognitive Drug Research Ltd - New Partnership Provides Single Source for Cognitive Analysis of Food and Nutrition Products

Collegium Pharmaceutical, Inc. - Collegium Pharmaceutical Inc. Announces Notice of Allowance for U.S. Patent Covering its Novel Combination Allergic Rhinitis Product

Committee for Truth in Psychiatry - New Book Highlights Human Cost of FDA's Failure to Investigate Medical Devices

Cook Medical - Cook Medical Brings Advanced Endovascular Thoracic Aneurysm Treatment to Canadians

Depression - Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder

Diabetes - Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009

Drug Development - Proteon Therapeutics Completes Second Closing of Equity Financing; Raises Total Series B to $50 million

DSP Clinical Research - Darlene Panzitta, President and Founder of DSP Clinical Research, Named Ernst & Young Entrepreneur of the Year 2009 Award Finalist

Epilepsy - Vimpat(R) (lacosamide) C-V, a New Antiepileptic Drug (AED), To Be Available in U.S. Pharmacies

Gene Therapy - AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria

Genentech, Inc. - Genentech and Biogen Idec Submit Applications to the FDA for Rituxan for Most Common Type of Adult Leukemia

Generics - Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)

Genzyme Corporation - Genzyme Submits All Information Requested by FDA for Lumizyme

Grocery Manufacturers Association - The Grocery Manufacturers Association GMA Issued the Following Statement by Its President and CEO, Pamela G. Bailey, in Response to Draft Food Safety Legislation Released Today by House Energy and Commerce Committee Chairman,

Heart Transplants - Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients

HST Global, Inc. - HST Global Signs Agreement to Acquire Central American Immunotherapy Company

Hypertension - FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension

International Stem Cell Corporation - International Stem Cell Corporation Reports Positive Pre-Clinical Trial Results From Human Corneal Epithelial Cells

Leukemia - Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338

Lifeline Biotechnologies, Inc. - Lifeline Biotechnologies, Inc. Prepares an FDA Filing

Medtronic, Inc. - Medtronic Announces FDA Approval of Two Deep Brain Stimulation Devices That Offer Programming Advances and New Tools for Patients with Movement Disorders

Memgen - Memgen’s ISF35 Clinical Trial Featured at ASCO Annual 2009 Meeting

MicroPhage, Inc. - MicroPhage Results on Rapid S. aureus/MRSA Blood Culture Test Published

Mutualink, Inc. - Mutualink’s Interoperable Communications Platform to Power NJ Regional Pandemic Network

National Press Club - NPC Newsmaker Program Hosts Briefing on Health Care Reform with Former HHS Secretary Michael Leavitt and Former Senate Majority Leader Tom Daschle

Nisola LLC - In the Case of Epilepsy, Generic Drugs and Random Product Substitution are Not Always “Good Medicine”

Oculus Innovative Sciences, Inc. - Oculus Innovative Sciences Receives FDA Clearance for Microcyn® Skin and Wound Gel

Pancreatic Cancer - FDA Clears Boston Scientific's SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System

Pharmaceuticals - Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year 2009, Updates on FDA Inspection

Pharmaceuticals - Classwide Opioids REMS: a Good Idea, Implement Carefully

Pharmaceuticals - Prix Galien USA Now Accepting Nominations for Premiere Biopharmaceutical Industry Award

Pharmaceuticals - Process for Planning Safe Pain Treatment Outlined in Presentation at FDA Meeting

Primus Pharmaceuticals, Inc. - New Patent Issued for Limbrel®

Public Health - County and City Leaders Coordinate to Just Be Ready

Red Bull - Red Bull Simply Cola

Regulatory Actions - Advanced Life Sciences Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Restanza(TM) (cethromycin)

Renaissance Health Sciences - NutriCompliance Certifies Advanced Red Wine Supplement Revatrol

Research - 'Happy hour' gene discovery suggests cancer drugs might treat alcoholism

Research and Markets - The Pharmaceutical Market: Italy

Research and Markets - The Q2 2009 Singapore Pharmaceuticals and Healthcare Report Provides Independent Forecasts and Competitive Intelligence on the Industry

SAS - SAS Hosts American TV Icon Jerry Mathers, Now Diabetes Patient Advocate

Seattle Genetics, Inc. - Seattle Genetics to Present SGN-35 and Lintuzumab Clinical Data at the European Hematology Association Congress

Seizure - Inventor of Newly Available Vimpat(R) (lacosamide) C-V Meets a Woman Who Experienced Greater Seizure Control With Use of This New Antiepileptic Drug

Stent System - FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System

Surgery - SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R)

Taro Pharmaceutical Industries Ltd. - Taro Receives FDA Approval for Sulfacetamide Sodium Topical Suspension ANDA

Tissue Engineering - Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting

U.S. Department of Justice - Doctor Charged With Writing Prescriptions Over the Internet for People Whom He Had Never Met or Examined

University of Illinois at Chicago - Diabetes drug shows promise against multiple sclerosis

XenaCare - XenaCare Holdings Receives Exclusive License to Market and Distribute an FDA Approved Over the Counter Treatment for Chronic Pain



Return to Top of Page

-----------------------
PR Login